Ultrasound Ablation Offers Option for Some With Prostate Cancer

WEDNESDAY, Sept. 16, 2020 -- For men with localized prostate cancer, hemigland high-intensity focused ultrasound (HIFU) ablation is associated with 73 percent two-year survival free from treatment failure and 91 percent survival free from radical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news